Depression and coronary heart disease: a review for cardiologists

R M Carney1, K E Freedland, Y I Sheline

  • 1Department of Psychiatry, Washington University School of Medicine, St. Louis, MO 63178, USA.

Clinical Cardiology
|March 1, 1997
PubMed

Insights

Major depression frequently co-occurs with coronary heart disease (CHD). Recognizing and treating depression in cardiac patients is crucial for improving recovery and reducing cardiac risks.

Area of Science:

  • Cardiology
  • Psychiatry
  • Psychosomatic Medicine

Background:

  • Major depression is a common comorbidity in patients with coronary heart disease (CHD).
  • Depression significantly complicates recovery and increases risks of cardiac morbidity and mortality.
  • It is often overlooked but treatable in most cardiac patients.

Purpose of the Study:

  • To review evidence on the negative prognostic impact of depression in cardiac patients.
  • To discuss current methods for assessing depression in this population.
  • To outline effective treatment strategies for depression in patients with CHD.

Main Methods:

  • Literature review of studies examining depression and CHD outcomes.
  • Synthesis of evidence on depression assessment tools.
  • Review of treatment modalities for comorbid depression and CHD.

Main Results:

  • Depression is associated with poorer prognosis and increased mortality in CHD patients.
  • Effective assessment tools are available for identifying depression in cardiac settings.
  • Evidence supports the efficacy of various treatments for depression in this cohort.

Conclusions:

  • Major depression is a serious complication of CHD that requires clinical attention.
  • Early identification and management of depression are vital for cardiac patient outcomes.
  • Treatment of depression can significantly improve recovery and reduce cardiovascular risks.

Related Concept Videos

Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...